NRx Pharmaceuticals, Inc.
NRXP

$16.55 M
Marketcap
$1.54
Share price
Country
$0.01
Change (1 day)
$7.33
Year High
$1.49
Year Low
Categories

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.

marketcap

NRx Pharmaceuticals, Inc. (NRXP) - Company Outlook



Company Outlook

Year Receivables Debt Liabilities Assets Current Assets
2023 6 K 4.57 M 19.05 M 7.32 M 6.88 M
2022 7 K -9,529,000 18.41 M 25.82 M 25.8 M
2021 -27,087,000 11.92 M 32.73 M 32.71 M
2020 831 K -1,062,000 46.71 M 2.94 M 2.93 M
2019 1.95 M 2.57 M 32.07 M 69.49 K